Vivek Kanpa, studies Artificial Intelligence for Medicine & Medical Research at University College Dublin. In the fall of 2024, he will begin his PhD studies in AI & Emerging Technologies for Medicine at the Icahn School of Medicine at Mount Sinai. A resident of Livingston, New Jersey, he graduated from Northeastern University, with degrees in Data Science and Biology. Vivek is interested in linking gene expression patterns and machine learning to oncology. He conducted impressive STEM research while still in high school evaluating social motivations for self-deception in the medial prefrontal cortex using transcranial magnetic stimulation. The findings were presented at national conferences and published in the Journal of Brain Sciences. Vivek received the PEAK Trail-Blazer award for investigating how oxidative stress impacts aging in nematode C. elegans neuronal tissue to explain pathogenesis of age-associated neurodegenerative disorders in humans, such as Alzheimer’s. At Takeda Pharmaceutical, he developed software tools that accelerate laboratory workflows in immunotherapy lead discovery. He then took his curiosity for targeted therapies to Revolution Medicines, where he focused on pharmacogenomics, the study of how genes effect a person’s response to drugs and developed a neural network to predict successful tumor penetration of anti-cancer drugs. Vivek is a distance runner, who will run the Connemarthon in Ireland. He was a top 50 finisher in a California 500-mile race. Vivek was also a Teaching Assistant in the Computer Science, Biology and Engineering Departments at Northeastern, and he connects with prospective students from historically underrepresented communities as an Access & Diversity Fellow.

Links